Literature DB >> 35237103

Transanal Endoscopic Platforms: TAMIS versus Rigid Platforms: Pros and Cons.

Liam A Devane1, Meghan C Daly2, Matthew R Albert2.   

Abstract

Transanal endoscopic surgery encompasses the minimally invasive surgical techniques used to operate in the rectum under magnification while maintaining pneumorectum via a resectoscope or port. The view, magnification, and surgical precision afforded by these advanced transanal techniques have resulted in excellent specimen quality and low recurrence rates, especially compared with traditional transanal surgery. For rigid platforms, the surgeon operates through a rigid 4-cm diameter steel proctoscope of varying lengths that is clamped to the operating table with an articulating arm. Transanal minimally invasive surgery (TAMIS) is a newer flexible platform using a disposable port which "hooks" into the anorectal ring to remain in place. The cost-effectiveness and versatility of the TAMIS platform have resulted in its popularity and use in more advanced applications such as transanal total mesorectal excision. Ultimately, the choice of operating platform should be based on surgeon preference, patient characteristics, availability, and cost. The pros and cons of each platform will be discussed in this article. Thieme. All rights reserved.

Entities:  

Keywords:  TAMIS; TEM; TEO; transanal endoscopic surgery

Year:  2022        PMID: 35237103      PMCID: PMC8885160          DOI: 10.1055/s-0041-1742108

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  30 in total

1.  Why the Conventional Parks Transanal Excision for Early Stage Rectal Cancer Should Be Abandoned.

Authors:  Sam Atallah; Deborah Keller
Journal:  Dis Colon Rectum       Date:  2015-12       Impact factor: 4.585

2.  TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors.

Authors:  F Van den Eynde; J Jaekers; S Fieuws; A M D'Hoore; A M Wolthuis
Journal:  Tech Coloproctol       Date:  2019-03-11       Impact factor: 3.781

3.  Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases.

Authors:  Marta Penna; Roel Hompes; Steve Arnold; Greg Wynn; Ralph Austin; Janindra Warusavitarne; Brendan Moran; George B Hanna; Neil J Mortensen; Paris P Tekkis
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

4.  Insufflation stabilization bag (ISB): a cost-effective approach for stable pneumorectum using a modified CO2 insufflation reservoir for TAMIS and taTME.

Authors:  A Waheed; A Miles; J Kelly; J R T Monson; J S Motl; M Albert
Journal:  Tech Coloproctol       Date:  2017-11-14       Impact factor: 3.781

5.  What is the best tool for transanal endoscopic microsurgery (TEM)? A case-matched study in 74 patients comparing a standard platform and a disposable material.

Authors:  Diane Mege; Valérie Bridoux; Léon Maggiori; Jean-Jacques Tuech; Yves Panis
Journal:  Int J Colorectal Dis       Date:  2016-12-24       Impact factor: 2.571

6.  NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance.

Authors:  Patricia Sylla; David W Rattner; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2010-02-26       Impact factor: 4.584

7.  Study of anorectal function after transanal endoscopic surgery.

Authors:  L Mora López; X Serra Aracil; J Hermoso Bosch; P Rebasa; S Navarro Soto
Journal:  Int J Surg       Date:  2014-12-06       Impact factor: 6.071

8.  Transanal endoscopic microsurgery: a single surgeon's experience.

Authors:  T J Saclarides
Journal:  Arch Surg       Date:  1998-06

9.  Transanal minimally invasive surgery for benign and malignant rectal neoplasia.

Authors:  Elisabeth C McLemore; Lynn A Weston; Alisa M Coker; Garth R Jacobsen; Mark A Talamini; Santiago Horgan; Sonia L Ramamoorthy
Journal:  Am J Surg       Date:  2014-04-01       Impact factor: 2.565

10.  St.Gallen consensus on safe implementation of transanal total mesorectal excision.

Authors:  Michel Adamina; Nicolas C Buchs; Marta Penna; Roel Hompes
Journal:  Surg Endosc       Date:  2017-12-12       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.